{
USA

Country

}
Accenture insider sales and institutional investments highlight market activity and trends
Accenture's COO sold shares at an average price of $373.24, totaling $1.87 million, reducing their stake by 22.13%. Over the past 90 days, insiders sold 36,298 shares worth $13.37 million, while institutional investors now hold 75.14% of the company. UBS Group raised its price target for Accenture to $455, indicating a potential upside of 21.39%.
MarketBeat
UBS Group AG Accenture plc Holocene Advisors LP Clearbridge Investments LLC USA John F. Walsh Julie Sweet Show more
Finance & Economy, Market Report
15:44 20.12.2024
darden restaurants insider trading activity and hedge fund investments update
Darden Restaurants' senior vice president now owns 3,834 shares valued at $659,601.36 after a significant 59.81% reduction in their position. Over the past three months, insiders sold 59,265 shares worth $10.1 million, while hedge funds hold 93.64% of the stock. UBS Group raised its price target for Darden from $195 to $210, indicating a potential upside of 15.21%.
MarketBeat
Darden Restaurants, Inc. USA Nana Mensah
Finance & Economy, Market Report
15:44 20.12.2024
darden restaurants insider trading activity and hedge fund investments update
Darden Restaurants' senior vice president now owns 3,834 shares valued at $659,601.36 after a significant 59.81% reduction in their position. Over the past three months, insiders sold 59,265 shares worth $10.1 million, while hedge funds control 93.64% of the stock. UBS Group raised its price target for Darden from $195 to $210, indicating a potential upside, as analysts maintain a "Moderate Buy" rating.
MarketBeat
Darden Restaurants, Inc. USA Nana Mensah
Finance & Economy, Market Report
15:44 20.12.2024
sachetta and ivc wealth advisors increase stakes in fedex stock
Sachetta LLC increased its FedEx stake by 29.1% in Q2, owning 164 shares valued at $49,000, while IVC Wealth Advisors raised its position by 2.0% in Q3, holding 1,948 shares worth $533,000. Institutional investors control 84.47% of FedEx's stock, which has a "Moderate Buy" rating with a consensus target price of $322.48. Recently, UBS Group raised its price target for FedEx to $350.00, indicating a potential upside of 17.35%.
MarketBeat
FedEx Corporation USA
Finance & Economy, Market Report
15:44 20.12.2024
sachetta and ivc wealth advisors increase stakes in fedex stock
Sachetta LLC increased its FedEx stake by 29.1% in Q2, owning 164 shares valued at $49,000, while IVC Wealth Advisors raised its position by 2.0% in Q3, holding 1,948 shares worth $533,000. Institutional investors control 84.47% of FedEx's stock, which has a "Moderate Buy" rating and a consensus target price of $322.48. Recent earnings showed a slight revenue decline, with EPS of $4.05 surpassing estimates.
MarketBeat
FedEx Corporation USA
Finance & Economy, Market Report
15:44 20.12.2024
verizon communications sees increased institutional investment and positive analyst ratings
Janney Montgomery Scott LLC increased its stake in Verizon Communications, owning over 2 million shares valued at $92.4 million, while Charles Schwab Investment Management raised its holdings to 101 million shares worth $4.5 billion. Analysts maintain a "Hold" rating, with a consensus target price of $46.51, despite recent earnings beating estimates. Verizon's stock opened at $39.90, with a market cap of $168 billion and a P/E ratio of 17.20.
MarketBeat
Verizon Communications Inc. USA
Finance & Economy, Market Report
15:43 20.12.2024
verizon communications sees increased institutional investment and positive analyst ratings
Janney Montgomery Scott LLC increased its stake in Verizon Communications to over 2 million shares, while Charles Schwab Investment Management raised its holdings to over 101 million shares. Analysts maintain a "Hold" rating on the stock, with a consensus target price of $46.51, despite recent earnings beating estimates. Institutional investors own 62.06% of Verizon's stock, reflecting strong interest in the telecommunications sector.
MarketBeat
Verizon Communications Inc. USA
Finance & Economy, Market Report
15:43 20.12.2024
credit suisse inquiry reveals management failures and regulatory shortcomings
The Parliamentary Commission of Inquiry concluded that Credit Suisse's downfall in March 2023 stemmed from years of mismanagement by its Board and management, rather than federal authorities' actions. The report criticized delays in decision-making and a lack of coordination among officials, emphasizing the need for reforms in oversight and emergency planning for systemically important banks. Despite the challenges, the federal authorities managed to maintain Credit Suisse's solvency during the crisis, averting a global financial disaster.
rts.ch
United States Dollar Credit Suisse Real Estate Fund Siat USA CHE Karin Keller-Sutter Agnès Wuthrich Ueli Maurer Show more
Finance & Economy, News Article
15:37 20.12.2024
US stocks decline as government shutdown fears and inflation data weigh down markets
US stocks fell on Friday as the House voted against a Trump-backed spending bill, raising the likelihood of a government shutdown. The Nasdaq Composite led losses with a 0.8% drop, while the S&P 500 and Dow Jones fell 0.4% and 0.1%, respectively. Key inflation data showed a month-over-month deceleration in price increases, but inflation remains a concern for the Federal Reserve.
Yahoo Finance
United States Dollar Novo Nordisk A/S Tesla, Inc. USA Donald Trump Joe Biden
Finance & Economy, Market Report
15:31 20.12.2024
crispr therapeutics gains momentum with new fda designation for cell therapy
CRISPR Therapeutics has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for its cell therapy CTX112, aimed at treating relapsed or refractory B-cell malignancies. This designation allows for a potentially expedited approval process, offering financial flexibility and a simpler manufacturing approach. While the new development is promising, the success of CTX112 still hinges on convincing safety and efficacy data in clinical trials.
@AOL
Vertex Pharmaceuticals Inc Apple Inc. NVIDIA Corporation Netflix, Inc. CRISPR Therapeutics AG USA Alex Carchidi Show more
Healthcare, Market Report
15:30 20.12.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Central Bank Actions Market Sentiment Analysis Corporate Responsibility & ESG Banking Regulations Decentralized Finance (DeFi) Innovations Cryptocurrency & Blockchain Regulations Inflation Rates & CPI Data Tokenomics and Crypto Economics Cryptocurrency Regulations Mergers & Acquisitions Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Hedge Funds & Private Equity SEC & Financial Compliance Blockchain Technology Adoption ESG & Sustainable Finance Regulations Cryptocurrency Developments
Countries:
USA CHE JPN CHN DEU AUS IND KOR HKG SGP TWN THA GBR RUS CAN FRA AUT BRA SAU IDN
Companies:
Ripples USD Solana USD Credit Suisse Real Estate Fund Siat Coinbase Global, Inc. Apple Inc. BlackRock, Inc. MicroStrategy Incorporated NVIDIA Corporation Ethereum USD Tesla, Inc. Cardano USD Volkswagen AG Hon Hai Precision Industry Co., Ltd. Google Inc. Bitwise Bitcoin ETF Chainlink USD Amazon.com, Inc. MicroStrategy Inc Tether USDt CNY Kraken Energy Corp.
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Chinese Yuan South Korean Won Singapore Dollar Canadian Dollar Colombian Peso Indian Rupee Hong Kong Dollar Seychellois Rupee Philippine Peso Malaysian Ringgit
People:
Donald Trump Ali Martinez Elon Musk Jerome Powell Michael J. Saylor Paul Atkins Gary Gensler David O. Sacks Charles Hoskinson Wiley Nickel Joe Biden Sriram Krishnan Bo Hines Karin Keller-Sutter Bill Gates Fred Thiel Jack Dorsey Jacob King Brian Armstrong Aaron Green

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.